Related Experiment Video
Updated: Jun 27, 2026

06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Increased cardiovascular mortality after early bilateral oophorectomy
Cathleen M Rivera1, Brandon R Grossardt, Deborah J Rhodes
1Division of Preventive and Occupational Medicine, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA.
Summary
Bilateral oophorectomy before age 45 increases cardiovascular disease mortality, particularly cardiac events. Estrogen therapy may mitigate this heightened risk in premenopausal women.
Area of Science:
- Reproductive Endocrinology
- Cardiovascular Disease Epidemiology
- Surgical Menopause
Background:
- Oophorectomy, the surgical removal of ovaries, can induce premature menopause.
- Cardiovascular disease (CVD) is a leading cause of mortality in women.
- The long-term effects of oophorectomy on CVD mortality require further investigation.
Purpose of the Study:
- To examine CVD mortality rates in women who underwent premenopausal oophorectomy.
- To assess the impact of estrogen treatment on CVD mortality following oophorectomy.
Main Methods:
- A long-term cohort study in Olmsted County, MN, included women undergoing unilateral or bilateral oophorectomy before natural menopause (1950-1987).
- Oophorectomy patients were age-matched with a control group of women who did not undergo oophorectomy.
- Mortality data for cardiovascular disease was analyzed for 1,274 unilateral oophorectomy, 1,091 bilateral oophorectomy, and 2,383 referent women.
Main Results:
- Unilateral oophorectomy was associated with reduced CVD mortality (HR, 0.82; P=0.04).
- Bilateral oophorectomy before age 45 significantly increased CVD mortality (HR, 1.44; P=0.04).
- This increased risk in bilateral oophorectomy patients was pronounced in those not receiving estrogen therapy (HR, 1.84; P=0.001) but not in estrogen-treated women (HR, 0.65; P=0.28).
Conclusions:
- Premenopausal bilateral oophorectomy before age 45 is linked to elevated cardiovascular mortality, especially cardiac mortality.
- Estrogen replacement therapy appears to reduce the increased cardiovascular mortality risk associated with bilateral oophorectomy.
- These findings highlight the importance of considering hormone therapy post-oophorectomy to mitigate cardiovascular risks.
Related Concept Videos
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
